XLV
HealthcareState Street Health Care Select Sector SPDR ETF
State Street · Tracks Health Care Select Sector Index · Inception Dec 16, 1998
Trailing returns
through Oct 23, 2026- 1 year
- +27.8%
- 3 year
- +15.2%
- annualized
- 5 year
- +8.0%
- annualized
Price return from month-end closes, distributions reinvested at month end. Excludes trading costs, bid-ask spreads and taxes. Past performance says nothing about future returns and is not part of the composite score — see the methodology for what the score does measure.
Composite score
Based on a 0.080% expense ratio.
Based on $43.39B in net assets.
Top-10 holdings represent 61.5% of net assets.
Healthcare base · ETF wrapper · 1.42% TTM yield.
The composite is a weighted average of the four core sub-scores above (cost, tax efficiency, liquidity, concentration). Missing sub-scores fall back to the per-category median when the category has at least 50% data coverage, so funds without (e.g.) parsed N-PORT holdings aren't accidentally boosted by renormalization. Tracking quality is shown where computable but isn't currently part of the composite weighting. See methodology for formulas, the tracking-quality partial-coverage rationale, and the dimensions we deliberately don't score (methodology v0.5.2).
Look through XLV, or compare the fee
Tool · Look-through
Underlying holdings, with other funds added
Add tickers and weights; N-PORT positions are summed across the basket.
Tool · Cost
Compare XLV's fee against another fund
Compounds the 0.080% expense ratio against a peer over decades.
Tool · Overlap
Compare XLV's holdings with peers
Pairwise holdings heatmap, pre-loaded with similar Healthcare funds.
Tool · TLH
Find a tax-loss harvesting partner for XLV
Ranks every catalog fund by holdings overlap, flags wash-sale risk.
Tool · Placement
Asset location for XLV across account types
Asset-location optimizer — places each fund in taxable / tax-deferred / Roth.
Top holdings
| # | Holding | Weight |
|---|---|---|
| 1 | Eli Lilly & Co | 16.51% |
| 2 | Johnson & Johnson | 10.64% |
| 3 | AbbVie Inc | 7.74% |
| 4 | UnitedHealth Group Inc | 6.57% |
| 5 | Merck & Co Inc | 5.52% |
| 6 | Amgen Inc | 3.40% |
| 7 | Thermo Fisher Scientific Inc | 3.24% |
| 8 | Abbott Laboratories | 2.75% |
| 9 | Gilead Sciences Inc | 2.73% |
| 10 | Intuitive Surgical Inc | 2.45% |
Compare XLV with another fund
Or skim the closest-overlap funds below.
Similar ETFs by holdings overlap
Open XLV at a brokerage
Affiliate links — opening an account through these earns PlainIndex a one-time referral. Scoring is computed before any affiliate consideration; see our methodology and funding disclosure.